{"organizations": [], "uuid": "9e91ebf0f615ceec813f07c80b21fc6073f28166", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mabvax-therapeutics-says-reverse-s/brief-mabvax-therapeutics-says-reverse-stock-split-is-scheduled-to-be-effective-with-opening-of-trading-on-feb-16-idUSASB0C5XV", "country": "US", "domain_rank": 408, "title": "BRIEF-MabVax Therapeutics Says Reverse Stock Split Is Scheduled To Be Effective With Opening Of Trading On Feb 16", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T14:40:00.000+02:00", "replies_count": 0, "uuid": "9e91ebf0f615ceec813f07c80b21fc6073f28166"}, "author": "", "url": "https://www.reuters.com/article/brief-mabvax-therapeutics-says-reverse-s/brief-mabvax-therapeutics-says-reverse-stock-split-is-scheduled-to-be-effective-with-opening-of-trading-on-feb-16-idUSASB0C5XV", "ord_in_thread": 0, "title": "BRIEF-MabVax Therapeutics Says Reverse Stock Split Is Scheduled To Be Effective With Opening Of Trading On Feb 16", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "mabvax therapeutics holdings inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News  43 PM / Updated 12 minutes ago BRIEF-MabVax Therapeutics Says Reverse Stock Split Is Scheduled To Be Effective With Opening Of Trading On Feb 16 Reuters Staff 1 Min Read Feb 15 (Reuters) - MabVax Therapeutics Holdings Inc : * MABVAX THERAPEUTICS SCHEDULES PREVIOUSLY ANNOUNCED 1-FOR-3 REVERSE STOCK SPLIT TO REGAIN COMPLIANCE WITH NASDAQâ€˜S $1.00 MINIMUM BID PRICE MAINTENANCE REQUIREMENT * MABVAX THERAPEUTICS HOLDINGS INC - REVERSE STOCK SPLIT IS SCHEDULED TO BE EFFECTIVE WITH OPENING OF TRADING ON FEB 16, 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-15T14:40:00.000+02:00", "crawled": "2018-02-15T15:04:06.005+02:00", "highlightTitle": ""}